Roberta Bertorelle Selected Research

Roberta Bertorelle Research Topics

Disease

16	Neoplasms (Cancer) 09/2023 - 05/2007
4	Glioblastoma (Glioblastoma Multiforme) 05/2022 - 05/2008
4	Disease Progression 12/2020 - 02/2014
4	Glioma (Gliomas) 05/2015 - 03/2007
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2023 - 01/2022
3	Hairy Cell Leukemia 01/2023 - 12/2017
3	Rectal Neoplasms (Rectal Cancer) 01/2018 - 04/2011
2	Leukemia 09/2023 - 01/2018
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2023 - 01/2018
2	Lymphoma (Lymphomas) 01/2023 - 12/2020
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2023 - 01/2020
2	Hypertension (High Blood Pressure) 01/2018 - 01/2013
2	Hypoxia (Hypoxemia) 01/2017 - 04/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 12/2010
2	Adenocarcinoma of Lung 11/2015 - 12/2010
2	Colorectal Neoplasms (Colorectal Cancer) 02/2014 - 11/2008
2	Neuroblastoma 07/2012 - 06/2008
1	Proteinuria 04/2024
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 09/2023
1	Monoclonal Gammopathy of Undetermined Significance 01/2023
1	Paraproteinemias (Monoclonal Gammopathy) 01/2023
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Primary Myelofibrosis (Myelosclerosis) 01/2022
1	Polyneuropathies (Polyneuropathy) 01/2020
1	Essential Thrombocythemia 10/2019
1	Pheochromocytoma 01/2018
1	Paraganglioma (Paragangliomas) 01/2018
1	T-Cell Leukemia (Leukemia, T Cell) 01/2018
1	Necrosis 01/2017
1	Hypopituitarism (Sheehan's Syndrome) 03/2015
1	Cushing Syndrome 03/2015
1	Pituitary Neoplasms (Pituitary Adenoma) 03/2015
1	Cardiomyopathies (Cardiomyopathy) 09/2014
1	Genomic Instability 02/2014
1	Pathologic Complete Response 02/2014
1	Infections 11/2013
1	Multiple Myeloma 10/2013
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2013
1	Adenocarcinoma 12/2010

Drug/Important Bio-Agent (IBA)

7	Temozolomide (Temodar)FDA LinkGeneric 05/2022 - 10/2006
5	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 10/2006
4	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2018 - 08/2007
3	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 04/2011
2	Monoclonal AntibodiesIBA 09/2023 - 10/2019
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 12/2010
2	MethyltransferasesIBA 05/2022 - 10/2006
2	O-(6)-methylguanineIBA 05/2022 - 10/2006
2	ibrutinibIBA 12/2020 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2013
2	RNA (Ribonucleic Acid)IBA 01/2018 - 01/2018
2	Bevacizumab (Avastin)FDA Link 01/2017 - 01/2012
2	Adenosine Triphosphate (ATP)IBA 01/2015 - 10/2013
2	Messenger RNA (mRNA)IBA 02/2014 - 11/2008
2	Codon (Codons)IBA 02/2014 - 07/2012
1	CreatinineIBA 04/2024
1	UbiquitinIBA 09/2023
1	Ligases (Synthetase)IBA 09/2023
1	AntimetabolitesIBA 09/2023
1	Imatinib Mesylate (Gleevec)FDA Link 01/2023
1	Immunoglobulin M (IgM)IBA 01/2023
1	venetoclaxIBA 12/2020
1	purineIBA 12/2020
1	Myelin-Associated GlycoproteinIBA 01/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020
1	CalreticulinIBA 10/2019
1	CatecholaminesIBA 01/2018
1	embelinIBA 01/2018
1	X-Linked Inhibitor of Apoptosis ProteinIBA 01/2018
1	Bendamustine Hydrochloride FDA Link 12/2017
1	Rituximab (Mabthera)FDA Link 12/2017
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 05/2015
1	alpha-hydroxyglutarateIBA 05/2015
1	pasireotideIBA 03/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015
1	Oxygen (Dioxygen)IBA 01/2015
1	Mitotane (Lysodren)FDA Link 09/2014
1	MyogeninIBA 02/2014
1	Oncogene Proteins (Oncogene Protein)IBA 11/2013
1	immune RNA (I-RNA)IBA 11/2013
1	AntibodiesIBA 11/2013
1	silmitasertibIBA 10/2013
1	Daunorubicin (Cerubidine)FDA LinkGeneric 10/2013
1	Phosphotransferases (Kinase)IBA 10/2013
1	Casein Kinase II (Casein Kinase 2)IBA 10/2013
1	Angiogenesis InhibitorsIBA 01/2013
1	Tumor Biomarkers (Tumor Markers)IBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	prolyl-proline (Pro-Pro)IBA 07/2012
1	arginylprolineIBA 07/2012
1	arginylarginine (Arg-Arg)IBA 07/2012
1	Protein Isoforms (Isoforms)IBA 07/2012
1	CilengitideIBA 01/2012

Therapy/Procedure

12	Therapeutics 12/2023 - 03/2004
4	Drug Therapy (Chemotherapy) 09/2023 - 05/2008
4	Chemoradiotherapy 05/2022 - 05/2008
4	Radiotherapy 10/2015 - 10/2006
1	Aftercare (After-Treatment) 01/2020
1	Neoadjuvant Therapy 01/2018
1	Adjuvant Chemotherapy 11/2015